2MUELLER MM, BOMKE B, SERFRIED E. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases Throm Res, 2002,31;107 suppl1:s9-17.
3DREWS RE. Critical issues in hematology anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically in patients[J]. Clin Chest Med, 2003, 24(4): 607-622.
4BICK RL. Disseminated intravascular coagulation:a revieco of etiology, pathophysiology, diagnosis and managenent: guidelines for care[J]. Clin Appl Thromb hemost, 2002, 8(1): 1-31.
5BAKHSHI S, ARYA LS. Diagnosis and treatment of disseminated intravascular coagulation[J]. Indian Pediatr, 2003, 40(8): 721-730.
6NAKABAYASHI M, ASAMI M, NAKATANI A. Efficacy of antithrombin replacement therapy in severe early-onset preeclampsia[J]. Semin Thromb Hemost, 1999, 25(5): 463-466.
7HARADA N, OKAJIMA K, KUSHIMOTO, et al. Antithrombin Ⅲ reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin[J]. Blood, 1999, 93: 157-164.
8TOTAK G, SCHOBERSBERGER W, SCHLOESSER M, et al.Effects of antithrombinⅢ on tumor necrosis factor-alpha and interlukin-1 beta synthesis in vascular smooth muscular cell [J]. J Interferon Cytokine Res, 2001, 21: 1063-1069.
9UCHIBA M, OKAJIMA K. Antithrombin Ⅲ(ATⅢ) Provents LPS- induced pulmonary vascular injury: Novel biological activity of ATⅢ[J]. Semin Thromb Hemost, 1997, 23(6): 583-590.
10INTHRON D, HOFFAM JN, HARTL WH, et al. Antithrombin Ⅲ Supplementation in severe sepsis:beneficial effects on organ dysfunction[J]. shock, 1997, 8(5): 328-334.
